Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2023-08-18

FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for venlafaxine from Alembic Pharmaceuticals, resulting in labeling updates for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venlafaxine (Venlafaxine)

Snippet

SUPPL AP for VENLAFAXINE (VENLAFAXINE)